Measuring blood oxygen levels noninvasively in older adults with pulmonary hypertension
Noninvasive measurement of oxygenation using quantitative susceptibility mapping
This study is testing a safe and easy way to check how much oxygen is in the blood of older adults with pulmonary hypertension using MRI technology, which could help doctors catch the condition earlier and make better treatment choices.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11009897 on NIH RePORTER |
What this research studies
This research aims to develop a noninvasive method using cardiac quantitative susceptibility mapping (QSM) to measure blood oxygen saturation in patients, particularly those over 65 years old. By utilizing MRI technology, the study seeks to improve early diagnosis and treatment decisions for pulmonary hypertension (PH), a serious condition that affects a significant portion of older adults. The approach focuses on monitoring cardiac oxygenation without the risks associated with invasive procedures, making it safer and more practical for patients. The ultimate goal is to enhance clinical outcomes for individuals suffering from this progressive disorder.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 65 and older who may be at risk for pulmonary hypertension.
Not a fit: Patients under the age of 65 or those without pulmonary hypertension may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and safer diagnosis of pulmonary hypertension, improving treatment options and outcomes for patients.
How similar studies have performed: Previous research has shown promise in using noninvasive imaging techniques for assessing various cardiac conditions, suggesting potential success for this novel approach.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Spincemaille, Pascal — Weill Medical Coll of Cornell Univ
- Study coordinator: Spincemaille, Pascal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.